Related by context. Frequent words. (Click for all words.) 59 Phase 1b clinical 59 ARRY 57 investigational oral 56 PRX # 55 CRx 55 AEZS 55 Phase Ib 55 NKTR 55 Perifosine 55 PS# [001] 54 OXi# 54 selective inhibitor 54 Phase 2a trial 54 Phase IIa clinical 53 Debio 53 phase IIb 53 investigational drug 53 investigational compound 53 Preclinical studies 53 HDAC inhibitor 53 phase 2a 53 COPAXONE R 53 BAY #-# 53 Phase IIa trial 53 Phase 2a clinical 52 metastatic renal cell carcinoma 52 ISIS # 52 ITMN 52 kinase inhibitor 52 4SC 52 antiviral activity 52 CA4P 51 oritavancin 51 dose limiting toxicities 51 nucleoside 51 LEVADEX 51 Phase 1b 51 INGN 51 small molecule inhibitor 51 Phase 2b 51 CUDC 51 humanized monoclonal antibody 51 tolerability 50 preclinical studies 50 NGX# 50 Serdaxin 50 ALTU 50 Phase IIb clinical 50 receptor agonist 50 dose escalation study 50 receptor antagonist 50 Phase IIb trial 50 Marqibo 50 Phase 2a 50 relapsing remitting multiple sclerosis 50 pharmacodynamics 50 orally administered 50 MGCD# [001] 50 Phase IIa 50 IDX# 50 AP# [003] 50 pharmacodynamic 49 pharmacokinetic 49 pharmacokinetic profile 49 Phase 2b study 49 double blind placebo 49 Azixa 49 RDEA# 49 mixed dyslipidemia 49 monotherapy 49 tolerability profile 49 single ascending dose 49 INCB# [002] 48 TREANDA 48 Bronchitol 48 Phase 2b clinical 48 tolerated dose MTD 48 Phase III clinical 48 ZYBRESTAT 48 potent inhibitor 48 ALKS 48 Nimotuzumab 48 pharmacokinetics 48 bevirimat 48 IMGN# 48 Phase IIb 48 ProLindac 48 blind randomized placebo 48 antisense drug 48 Phase III trials 48 lacosamide 48 HCV infected 48 label dose escalation 47 Phase 2b trial 47 mg doses 47 kinase inhibitors 47 NexACT 47 refractory multiple myeloma 47 TMC# [001] 47 azacitidine 47 cutaneous T cell